Literature DB >> 31839339

Evaluating unplanned readmission and prolonged length of stay following minimally invasive surgery for endometrial cancer.

Adrian Kohut1, Mary Cathryn Earnhardt2, Nicholas G Cuccolo2, Chi-Son Kim3, Mihae Song2, Eugenia Girda2, Alexandre Buckley De Meritens2, Ruth Stephenson2, Adrian Balica2, Aliza Leiser2, Kitaw Demissie4, Lorna Rodriguez-Rodriguez5.   

Abstract

OBJECTIVE: To evaluate risk factors for 30-day unplanned readmission and increased length of stay (LOS) following minimally invasive surgery (MIS) for endometrial cancer.
METHODS: This was a retrospective, case-control study using the American College of Surgeons National Surgical Quality Improvement Program (ACS NSQIP). Multivariable logistic regression was used to assess perioperative variables associated with readmission and increased LOS after MIS for endometrial cancer.
RESULTS: The study population included 10,840 patients who met the criteria of having undergone MIS with a resultant endometrial malignancy confirmed on postoperative pathology. Common reasons for readmission included organ/space surgical site infection (65 cases), sepsis/septic shock (19 cases), and venous thromboembolism (20 cases). Notable risk factors for readmission included (Odds Ratio, Confidence Interval, p-value): dialysis dependence (6.77, 2.51-17.80, <0.01), increased length of stay (3.00, 2.10-4.10, <0.01), and preoperative weight loss (2.80, 1.06-7.17, 0.03); notable risk factors for increased LOS: ascites (8.51, 2.00-36.33, <0.01), operation duration >5 h (6.93, 5.29-9.25, <0.01), and preoperative blood transfusion (5.37, 2.05-14.04, <0.01).
CONCLUSIONS: Identification of risk factors for adverse postoperative outcomes is necessary to inform and improve standards of care in MIS for endometrial cancer. Using nationally reported data from the ACS NSQIP, this study identifies independent risk factors for unplanned readmission and prolonged LOS, and in doing so, highlights potential avenues for quality improvement.
Copyright © 2019. Published by Elsevier Inc.

Entities:  

Mesh:

Year:  2019        PMID: 31839339     DOI: 10.1016/j.ygyno.2019.08.023

Source DB:  PubMed          Journal:  Gynecol Oncol        ISSN: 0090-8258            Impact factor:   5.482


  4 in total

1.  Feasibility of combining pelvic reconstruction with gynecologic oncology-related surgery.

Authors:  Adrian Kohut; Taylor Whitaker; Logan Walter; Susan Y Li; Elinor Han; Stephen Lee; Mark T Wakabayashi; Thanh H Dellinger; Ernest S Han; Lorna Rodriguez-Rodriguez; Christopher Chung
Journal:  Int Urogynecol J       Date:  2022-05-02       Impact factor: 2.894

2.  Permanent stoma: a quality outcome in treatment of rectal cancer and its impact on length of stay.

Authors:  Riccardo Lemini; Iktej S Jabbal; Krystof Stanek; Shalmali R Borkar; Aaron C Spaulding; Scott R Kelley; Dorin T Colibaseanu
Journal:  BMC Surg       Date:  2021-03-25       Impact factor: 2.102

3.  Predictors of prolonged admission after outpatient female pelvic reconstructive surgery.

Authors:  Andrea M Simi; Graham C Chapman; Jacqueline Zillioux; Sarah Martin; Emily A Slopnick
Journal:  Neurourol Urodyn       Date:  2022-03-29       Impact factor: 2.367

Review 4.  Prehabilitation to Improve Outcomes of Patients with Gynaecological Cancer: A New Window of Opportunity?

Authors:  Joëlle Dhanis; Nathaniel Keidan; Dominic Blake; Stuart Rundle; Dieuwke Strijker; Maaike van Ham; Johanna M A Pijnenborg; Anke Smits
Journal:  Cancers (Basel)       Date:  2022-07-15       Impact factor: 6.575

  4 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.